Savient Pharma says court dismissed lawsuit - BusinessWeek

Savient Pharma says court dismissed lawsuit BusinessWeek ... a US district court dismissed a lawsuit alleging the company delayed disclosing serious side effects in clinical trials of its gout drug Krystexxa. ... Savient Pharmaceuticals Announces Dismissal of Class Action LawsuitPR Newswire (press release) all 31 news articles »

Savient Gout Drug Wins FDA OK; Firm for Sale - BioWorld Online

TopNews United Kingdom (blog)

Savient Gout Drug Wins FDA OK; Firm for Sale BioWorld Online ... was drawn from two multicenter, randomized, double-blind, placebo-controlled trials in patients with chronic gout refractory to conventional therapy. ... The FDA approves new drug for goutLos Angeles Times FDA Approves New Gout DrugMedPage Today News > New Gout Drug ApprovedArthritis Today MarketWatch (press release) -Examiner.com all 199 news articles »

BioCryst Reports Positive Results From A Phase 2 Study Of BCX4208 Combined ... - MarketWatch (press release)

BioCryst Reports Positive Results From A Phase 2 Study Of BCX4208 Combined ... MarketWatch (press release) Additionally, BioCryst has a third product candidate, BCX4208--a next generation PNP inhibitor--in mid-stage trials for the treatment of gout. ... BioCryst Drug Boosted Existing Gout Treatment In StudyWall Street Journal BioCryst gout drug shows promise in mid-stage trialReuters all 27 news articles »

Clinical Trials: Oct. 5, 2010 - Doctors Lounge

Clinical Trials: Oct. 5, 2010 Doctors Lounge Potential study candidates must be at least 18 years old and experiencing gout symptoms, such as pain, tenderness, swelling, redness, or warmth of the ...